Keyphrases
Idiopathic Intracranial Hypertension
100%
Intracranial Pressure
54%
Headache
45%
Intracranial Hypertension
19%
Mild Traumatic Brain Injury (mTBI)
16%
Increased Intracranial Pressure
16%
Bariatric Surgery
15%
Exenatide
15%
Migraine
14%
Glucagon-like peptide-1 Receptor (GLP-1R)
13%
Randomized Clinical Trial
12%
Weight Loss
11%
Cerebrospinal Fluid
10%
Weight Control
10%
Weight Management
9%
Obesity
9%
Glucagon-like
9%
Cognitive Performance
8%
Papilledema
7%
Erenumab
7%
Quality of Life
7%
Mitochondrial Dysfunction
7%
Metabolism
7%
Metabolic Dysregulation
7%
Narrative Review
7%
Intracranial Pressure Measurement
7%
Body Mass Index
7%
Calcitonin Gene-related Peptide Monoclonal Antibody
6%
NMR Spectroscopy
6%
Phenotypic Patterns
6%
Military Personnel
6%
Post-traumatic Headache
6%
PITX2
6%
Adjusted Means
6%
Pressure Reduction
6%
Novel Metabolic Pathway
6%
Migraine Pathophysiology
6%
Transcriptional Dysregulation
6%
Adipocyte
6%
Label Evaluation
6%
Optical Coherence Tomography
6%
Cost-effectiveness
6%
Single-payer Health Care
6%
Telemetric Monitoring
6%
Health Systems
6%
Translational Relevance
6%
Metabolomics
6%
Metabolic Flux
6%
Idiopathic Intracranial Hypertension without Papilledema
6%
Ophthalmologist
6%
Medicine and Dentistry
Idiopathic Intracranial Hypertension
79%
Headache
41%
Intracranial Pressure
40%
Intracranial Hypertension
19%
Systematic Review
19%
Cerebrospinal Fluid
18%
Migraine
17%
Traumatic Brain Injury
16%
Bariatric Surgery
14%
Weight Management
14%
Diseases
14%
Pathophysiology
10%
Quality of Life
7%
Erenumab
7%
Gut
7%
Calcitonin Gene Related Peptide
7%
Mitochondrial Disorder
7%
NMR Spectroscopy
7%
Metabolomics
7%
Posttraumatic Headache
6%
Cardiac Muscle Cell
6%
Randomized Clinical Trial
6%
Health Care
6%
Adipocyte
6%
Cost-Effectiveness Analysis
6%
Optical Coherence Tomography
6%
Monoclonal Antibody
6%
Magnetic Resonance Imaging
6%
Gut Microbiome
6%
Topiramate
5%
Acetazolamide
5%
Neuroscience
Idiopathic Intracranial Hypertension
76%
Headache
44%
Exenatide
19%
Migraine
15%
Traumatic Brain Injury
13%
Neurotrauma
13%
Glucagon-Like Peptide-1 Agonist
12%
Calcitonin
12%
Papilledema
11%
Metabolic Pathway
8%
Glucagon-Like Peptide-1
7%
Allodynia
7%
Nuclear Magnetic Resonance Spectroscopy
7%
Body Mass Index
6%
Monoclonal Antibody
6%
Hypertension
6%
Acetazolamide
6%
Topiramate
6%
Magnetic Resonance Imaging
6%
Magnetic Resonance Imaging
6%